Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01520688 · ClinicalTrials.gov registry record · Phase 4
Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
A Phase 4 study of Asthma, sponsored by West Penn Allegheny Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT01520688 is a Phase 4 study of Asthma that has completed, run by West Penn Allegheny Health System. The registered enrollment target is 32 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01520688, a Phase 4 study of Asthma, has completed, sponsored by West Penn Allegheny Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
Children with mild persistent asthma that have asthma symptoms once or twice a week and use a daily controller, while children with mild intermittent asthma rarely have asthma symptoms and do not use a daily controller. Inhaled corticosteroids are the standard treatment for mild peristent asthma. The purpose of this study is to measure children rate of growth while on different inhaled corticosteroids.
Conditions Studied
Interventions
- DRUG Fluticasone, Budesonide, Beclomethasone
- DRUG Fluticasone, Beclomethasone, Budesonide
- DRUG Budesonide, Fluticasone, Beclomethasone
- DRUG Budesonide, Beclomethasone, Fluticasone
- DRUG Beclomethasone, Fluticasone, Budesonide
Study Locations (2)
Pennsylvania
- Pediatric Alliance-Greentree Division - Green Tree
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01520688
The ClinicalTrials.gov registry entry for NCT01520688 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is West Penn Allegheny Health System, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 5 interventions - of which Fluticasone, Budesonide, Beclomethasone is the first listed.
NCT01520688 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01520688 about?
NCT01520688 is a clinical study titled "Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth". Children with mild persistent asthma that have asthma symptoms once or twice a week and use a daily controller, while children with mild intermittent asthma rarely have asthma symptoms and do not use a daily controller. Inhaled corticosteroids are the standard treatment for mild peristent asthma. Th...
What is the current status of trial NCT01520688?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2012-02. Estimated completion is 2016-02.
What conditions does trial NCT01520688 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01520688?
The interventions under investigation include: Fluticasone, Budesonide, Beclomethasone (DRUG), Fluticasone, Beclomethasone, Budesonide (DRUG), Budesonide, Fluticasone, Beclomethasone (DRUG), Budesonide, Beclomethasone, Fluticasone (DRUG), Beclomethasone, Fluticasone, Budesonide (DRUG).
Who is sponsoring clinical trial NCT01520688?
This trial is sponsored by West Penn Allegheny Health System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01520688 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.